glp-1 drugs approved for weight loss GLP-1s Loss: What You Need to Know GLP-1 Agonists: A Comprehensive Overview
Description
Goud, A., Zhong, J., Peters, M., Brook, R

Diabetes Care (2022) 45(Suppl 1):S12543

These [medications] can help patients feel more full for longer or more full on less food, says Dr

The main adverse events of LIXI are gastrointestinal adverse reactions, mainly manifested as nausea and vomiting in the initial stage (75, 76)

Transformative Efficacy : The magnitude of weight loss achieved with GLP-1 agonists, particularly newer agents like tirzepatide, represents an unprecedented pharmacological achievement in obesity treatment

10.1016/S0140-6736(21)01324-6 83 RosenstockJ.FriasJ.JastreboffA
